Macquarie Group
AMPH icon

Macquarie Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Macquarie Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,707
Closed -$839K – 2307
2022
Q2 		$895K Hold
25,707
– – ﹤0.01% 1509
2022
Q1 		$923K Buy
25,707
+19,559
+318% +$555K ﹤0.01% 1561
2021
Q4 		$144K Buy
6,148
+5,694
+1,254% +$116K ﹤0.01% 1839
2021
Q3 		$9K Hold
454
– – ﹤0.01% 2545
2021
Q2 		$9K Hold
454
– – ﹤0.01% 2476
2021
Q1 		$8K Sell
454
-215
-32% -$4K ﹤0.01% 2409
2020
Q4 		$13K Hold
669
– – ﹤0.01% 2275
2020
Q3 		$13K Hold
669
– – ﹤0.01% 2237
2020
Q2 		$15K Buy
+669
New +$12.3K ﹤0.01% 2224

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Macquarie Group's AMPH Position: Q3 2022 in Review

Macquarie Group sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2022, closing a stake of 25,707 shares — an estimated $839K sold.

Macquarie Group first reported a position in AMPH in Q2 2020 and held it in 9 quarters. The position peaked at $923K in Q1 2022. 205 funds tracked by Wall St. Rank hold AMPH as of Q3 2022.

  • Macquarie Group reported no remaining Amphastar Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 25,707 Amphastar Pharmaceuticals shares in Q3 2022, an estimated $839K.
  • Macquarie Group first reported a position in Amphastar Pharmaceuticals in Q2 2020 and held it in 9 quarters.
  • Macquarie Group's Amphastar Pharmaceuticals position peaked at $923K in Q1 2022.
  • 205 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.